title: Anthracycline cardiotoxicity: a new paradigm for an old classic.
authors.affiliation: From Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA (J.D.G., A.N.); and Cardio-Oncology Program, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA (J.D.G., A.N.).
authors.forename: John D
authors.initials: JD
authors.lastname: Groarke
authors.affiliation: From Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA (J.D.G., A.N.); and Cardio-Oncology Program, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA (J.D.G., A.N.). anohria@partners.org.
authors.forename: Anju
authors.initials: A
authors.lastname: Nohria
mesh_terms: D000903:Antibiotics, Antineoplastic / Q000009:adverse effects*; D004317:Doxorubicin / Q000009:adverse effects*; D005260:Female; D006333:Heart Failure / Q000139:chemically induced* / Q000175:diagnosis*; D006801:Humans; D008297:Male
chemical_list: D000903:Antibiotics, Antineoplastic; D004317:Doxorubicin
keywords: Editorials; anthracyclines; cardiotoxicity